A number of technological achievements in the large health field accelerated productization, Huan Tong Tongjie and the National Medical Center of the National Medical Center held Holding Valley Biological City

Changjiang Daily Da Wuhan Client News The tracheal ducts that can control the pressure on their own can prevent inhaling pneumonia. During orthopedic surgery, use a syringe to inject bone cement into bone cement to fix the anchor nails. Do not increase calories ... These medical technology results from clinical needs are expected to complete the transformation and landing in the relay in Laoukou District and Donghu New Technology Development Zone.

A group of biomedical and clinical medical scientific research achievements were transformed at the China Technology Exchange Medical Technology Transformation Center. Reporter Wan Ling Photo

On July 8th, the collection of the Hubei (Biological Industry) project of the China Innovation Challenge and the Wuhan Biopharmaceutical Industry Innovation and Development Seminar was held at the Gaotou Chuanghui Da Health Industrial Park in Laotukou. During the event, Hubei High -Investment Yingzheng Medical Science and Technology Achievement Transformation Center Co., Ltd., Hubei High -Investment Chuanghui Industrial Park Operation Co., Ltd. and Wuhan National Biological Industry Innovation Base Co., Ltd. signed the Three Party Agreement to declare The industrialization process of the technological achievements of the biological city accelerated the major health field.

The reporter from the Yangtze River Daily saw at the China Technology Exchange Medical Technology Transformation Center (Hubei) that a number of biomedical and clinical medical treatment such as the "good" fairy juice, the breast ultrasound fault imaging system, the disposable flushing drainage pipe, the anorectal jacket, The scientific research results have changed from the paper to a model.

According to Chen Weidong, general manager of Hubei High -Investment Medical Science and Technology Achievement Transformation Center Co., Ltd., the center has been settled in Laoukou District since September 2019 to help domestic biomedical scientific researchers and front -line medical workers trading nearly 400 intellectual property rights, accumulated accumulated, accumulated accumulated Realize the amount of technical transaction nearly 90 million yuan. The company has hosted the Hubei Provincial Transformation Medical Innovation Contest and the Youth Entrepreneurship Contest. From the country to the 450 medical technology achievement transformation projects, 86 projects have been incubated, and 22 projects are actually invested, with an investment amount of 60 million yuan.

Huang Chaoxi, general manager of Wuhan National Biological Industry Innovation Base Co., Ltd., introduced that the Optics Valley Biological City brought together a group of entrepreneurial companies with academic background. The scientific research results of many academicians and experts from Tongji Hospital and Xiehe Hospital achieved industrialization in the Optics Valley Biological City. According to the layout of the "Wuhan Great Health Industry Development Plan (2019-2035)" on the "one city, one garden, three centers", the three parties reached a strategic cooperation, indicating that the Optics Valley Biological City and the Tongji Jiehe National Medical Center will cooperate in cooperation Development, the Optics Valley relying on the scientific research and clinical advantages of Tongji Medical College and Tongji Hospital and Xiehe Hospital, the production side is closer to patients, and the development direction of enterprises with clinical needs, while accelerating the transformation of the technological achievements of scientific research units and medical institutions in universities.

On the same day, the Wuhan Biomedical Engineering Society's medical science and technology achievement transformation special committee was established in High -Investment Chuanghui Da Health Industrial Park. 29 well -known local biomedical companies such as Mingde Biological and Youzhi Medical participated in the seminar. A number of enterprise representatives exchanged technical problems with front -line clinical experts and expressed their research and development needs for key core technologies.

Wang Xin, investment director of Kyushu Tong Pharmaceutical Group Co., Ltd., told reporters that Kyushu Tong is based on the traditional logistics industry and intends to enter the field of high -precision medical device products sales. Several technical results recommended will be in -depth through the connection with the R & D team through the platform.

(Changjiang Daily reporter Wan Ling Correspondent Zhan Ou Xia Xu)

【Edit: Zheng Xiaoxiao】

For more exciting content, please download the "Da Wuhan" client in the major application markets.

- END -